GE vs STRO
GE Aerospace (GE) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
GE Aerospace (GE) is a aerospace & defense company listed on NYSE. It is led by Larry Culp.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported GE revenue for 2025-12-31 was $45.85B. Net income was $8.70B. Revenue was up 324.1% from 2024-12-31 to 2025-12-31. GE currently screens at market cap $373.04B and trailing P/E 44.4.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
GE currently screens at market cap $373.04B and trailing P/E 44.4. STRO currently screens at market cap $470.8M.
Not investment advice. Open the GE and STRO stock pages for the full models.
Not investment advice.